Source document or public record
FDA 510(k) K220026 — Genomadix Cube CYP2C19 System
FDA 510(k) index record K220026. Device: Genomadix Cube CYP2C19 System. Applicant as listed: Genomadix, Inc.. Decision date: 2023-03-21.
Source
"device_name": "Genomadix Cube CYP2C19 System"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K220026.
Device name: Genomadix Cube CYP2C19 System. Applicant as listed: Genomadix, Inc..
Decision date: 2023-03-21. Decision wording: Substantially Equivalent.
Product code: NTI. Regulation: 21 CFR 862.3360. Medical specialty: Clinical Toxicology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.